Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-04-12 Sale | 2021-04-13 5:06 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $4.0725 | $40,725 | 496,824 (Direct) | View |
2021-01-13 Sale | 2021-01-15 4:03 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $6.0058 | $60,058 | 406,824 (Direct) | View |
2021-01-11 Sale | 2021-01-12 4:02 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $5.7244 | $57,244 | 416,824 (Direct) | View |
2020-12-09 Purchase | 2020-12-10 4:52 pm | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 10,000 | $4.0551 | $40,551 | 424,564 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-10-05 Disposition | 2021-10-05 5:38 pm | N/A 2028-05-15 | XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 62,106 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:38 pm | N/A 2028-05-15 | XERIS PHARMACEUTICALS INC | XERS | SHERMAN JEFFREY W Director | 62,106 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:37 pm | N/A 2028-05-15 | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 73,335 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:37 pm | N/A 2028-05-15 | XERIS PHARMACEUTICALS INC | XERS | HALKUFF DAWN Director | 62,106 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:36 pm | N/A 2027-01-27 | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Chief Executive Officer | 2,057,633 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:36 pm | N/A 2027-02-04 | XERIS PHARMACEUTICALS INC | XERS | Pieper Steven Chief Financial Officer | 232,018 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:34 pm | N/A 2022-02-23 | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 609,382 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:34 pm | N/A 2028-01-30 | XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks | 488,866 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:33 pm | N/A 2027-02-04 | XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks | 322,083 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:32 pm | N/A 2028-05-15 | XERIS PHARMACEUTICALS INC | XERS | PERSKY MARLA Director | 62,106 | $0 | 0 (Direct) | View |
2021-10-05 Disposition | 2021-10-05 5:32 pm | N/A 2027-02-03 | XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks | 692,349 | $0 | 0 (Direct) | View |
2021-07-28 Option Award | 2021-07-29 6:06 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Pieper Steven See Remarks | 100,000 | $0 | 158,858 (Direct) | View |
Ownership | 2021-07-29 6:04 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Pieper Steven See Remarks | 0 | $0 | 132,768 (Direct) | View |
2021-06-08 Option Award | 2021-06-08 7:11 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | PERSKY MARLA Director | 11,228 | $0 | 11,228 (Direct) | View |
2021-06-08 Option Award | 2021-06-08 7:10 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | SHERMAN JEFFREY W Director | 11,228 | $0 | 11,228 (Direct) | View |
2021-06-08 Option Award | 2021-06-08 7:09 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | HALKUFF DAWN Director | 11,228 | $0 | 11,228 (Direct) | View |
2021-06-08 Option Award | 2021-06-08 7:08 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director | 11,228 | $0 | 11,228 (Direct) | View |
2021-06-08 Option Award | 2021-06-08 7:08 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 11,228 | $0 | 11,228 (Direct) | View |
2021-01-29 Option Award | 2021-02-01 4:22 pm | N/A 2031-01-29 | XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks | 625,000 | $0 | 1,049,564 (Direct) | View |
2021-01-29 Option Award | 2021-02-01 4:20 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks | 150,000 | $0 | 271,224 (Direct) | View |
2021-01-29 Option Award | 2021-02-01 4:17 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 100,000 | $0 | 506,824 (Direct) | View |
2021-01-29 Option Award | 2021-02-01 4:12 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks | 65,000 | $0 | 91,890 (Direct) | View |
2021-01-29 Option Award | 2021-02-01 4:11 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks | 150,000 | $0 | 210,814 (Direct) | View |
2021-01-29 Option Award | 2021-02-01 4:06 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks | 115,000 | $0 | 208,090 (Direct) | View |
2020-12-16 Gift | 2020-12-17 4:40 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $0 | 426,824 (Direct) | View |
2020-08-18 Option Award | 2020-08-20 6:01 pm | N/A 2030-08-18 | XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks | 100,000 | $0 | 221,224 (Direct) | View |
2020-08-14 Option Award | 2020-08-17 4:35 pm | N/A 2030-08-14 | XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks | 100,000 | $0 | 126,890 (Direct) | View |
2020-08-14 Option Award | 2020-08-17 4:26 pm | N/A 2030-08-14 | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 25,000 | $0 | 461,824 (Direct) | View |
2020-08-14 Option Award | 2020-08-17 4:25 pm | N/A 2030-08-14 | XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks | 150,000 | $0 | 210,814 (Direct) | View |
2020-08-14 Option Award | 2020-08-17 3:45 pm | N/A 2030-08-14 | XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks | 100,000 | $0 | 193,090 (Direct) | View |
2020-06-30 Option Award | 2020-07-15 4:54 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks | 3,731 | $2.26 | 60,814 (Direct) | View |
2020-06-30 Option Award | 2020-07-15 4:53 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks | 3,731 | $2.26 | 121,224 (Direct) | View |
2020-06-30 Option Award | 2020-07-15 4:53 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks | 3,731 | $2.26 | 93,090 (Direct) | View |
2020-06-30 Option Award | 2020-07-15 4:52 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks | 775 | $2.26 | 26,890 (Direct) | View |
2020-06-04 Option Award | 2020-06-04 9:06 pm | N/A 2030-06-04 | XERIS PHARMACEUTICALS INC | XERS | SHERMAN JEFFREY W Director | 11,228 | $0 | 11,228 (Direct) | View |
2020-06-04 Option Award | 2020-06-04 9:04 pm | N/A 2030-06-04 | XERIS PHARMACEUTICALS INC | XERS | PERSKY MARLA Director | 11,228 | $0 | 11,228 (Direct) | View |